Loading
A phase 2 trial in pancreatic cancer, run by The University of Texas Health Science Center, Houston, now recruiting.
EUS-RFA PANCARDINAL-1 Trial is a phase 2, interventional study registered as NCT04990609 by The University of Texas Health Science Center, Houston, with a registry enrolment figure of 60 participants, started 2021-08-13 and due to reach its primary completion in 2026-12-01. Interventions recorded: Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA); Neoadjuvant Chemotherapy (NAC). Conditions listed: Pancreatic Ductal Adenocarcinoma (PDAC). Primary outcome: Number of participants who are able to complete neoadjuvant chemotherapy plus EUS-RFA and later undergo surgical tumor resection. Sites: United States. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.